ARTICLE | Company News
Onyx, Ono Pharmaceutical deal
September 13, 2010 7:00 AM UTC
Onyx granted Ono exclusive, Japanese rights to develop and commercialize two proteasome inhibitors for cancer. Onyx will receive about $59 million up front and is eligible for about $280 million in mi...